APA (7th ed.) Citation

Yıldız, S., Demir, H., Özüdoğru, T., Günenç, D., Gökdere, Z. S., Arvas, H., . . . İpek, Ş. A. (2026). Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group. Journal of Clinical Medicine, 15(6), 2353. https://doi.org/10.3390/jcm15062353

Chicago Style (17th ed.) Citation

Yıldız, Sedat, et al. "Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group." Journal of Clinical Medicine 15, no. 6 (2026): 2353. https://doi.org/10.3390/jcm15062353.

MLA (9th ed.) Citation

Yıldız, Sedat, et al. "Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group." Journal of Clinical Medicine, vol. 15, no. 6, 2026, p. 2353, https://doi.org/10.3390/jcm15062353.